about
A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA SequencingUsing genetic mouse models to gain insight into glaucoma: Past results and future possibilities.Expansions of the neurovascular scleral canal and contained optic nerve occur early in the hypertonic saline rat experimental glaucoma model.Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.Severe Corticosteroid-Induced Ocular Hypertension Requiring Bilateral Trabeculectomies in a Patient with Takayasu's Arteritis.Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork.Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.Experimental circumferential canaloplasty with a new Schlemm canal microcatheter.Methods to Induce Chronic Ocular Hypertension: Reliable Rodent Models as a Platform for Cell Transplantation and Other Therapies.In Vivo Small Molecule Delivery to the Optic Nerve in a Rodent Model.Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
P2860
Q28469378-F927D7DE-52FC-4444-BC82-125244F1A704Q36236937-1B9F1343-EA6F-4207-8B2A-4125336CB6BEQ36827480-C72CEC2B-6CDA-4871-9B7F-0E6399F75BD1Q36880023-591C393E-CC7F-4765-A873-1E784269733DQ37059858-43FEAA4D-8410-4E39-AE08-39F432591554Q37434479-28A11AC4-9118-4CFB-B82A-040AFA5FF246Q38963936-57DFFE5E-685D-4418-9BF1-0590D65FCD16Q43991565-247BC215-1E19-42B0-AA35-8F62A73578E9Q44560624-CCF8EBA0-FC0A-49C3-BBF5-492EC891B483Q47333845-EC8C41D1-7B49-48A9-983F-AFB3CEE550BEQ47954026-8BEEAA0F-DB13-4DF2-8EA2-00B27FE84995Q49265417-ECFB554C-5BD0-42EF-963F-B673ACC941ABQ52594562-1CA00813-7382-40F4-9F63-802369C06C03Q52657296-1BF8AE0B-7BBF-4664-BD65-2BCC92E93B74Q54979452-0E680903-E042-460D-9ABB-07594E56A34F
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Animal models of glucocorticoid-induced glaucoma
@ast
Animal models of glucocorticoid-induced glaucoma
@en
Animal models of glucocorticoid-induced glaucoma
@nl
type
label
Animal models of glucocorticoid-induced glaucoma
@ast
Animal models of glucocorticoid-induced glaucoma
@en
Animal models of glucocorticoid-induced glaucoma
@nl
prefLabel
Animal models of glucocorticoid-induced glaucoma
@ast
Animal models of glucocorticoid-induced glaucoma
@en
Animal models of glucocorticoid-induced glaucoma
@nl
P2860
P1476
Animal models of glucocorticoid-induced glaucoma
@en
P2093
Abbot F Clark
P2860
P356
10.1016/J.EXER.2015.06.002
P407
P577
2015-06-04T00:00:00Z